Business Description
Neurogene Inc. is a New York-based company founded in 2018 that focuses on developing treatments for rare brain and nervous system disorders. Its two lead programs are currently in early-stage clinical trials ? one targeting Rett syndrome and another aimed at CLN5 Batten disease, both of which are serious conditions with very limited treatment options. The company works under licensing agreements with several academic and research institutions to support its drug development efforts.
